A single-center retrospective study of patients treated with trabectedin (TRB) with long-term follow up.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2019.37.15_suppl.11061
Abstract: 11061 Background: TRB is FDA approved drug for the treatment of liposarcoma (Lipo) and leiomyosarcoma (LMS). The aim of this study was to evaluate potential biomarkers associated with prolonged benefit in patients treated with TRB… read more here.
Keywords: patients treated; trb cycles; study; center ... See more keywords